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Summary
A 147-day study was conducted to deter-
mine the sequential growth responses and serum
hormone profiles of growing heifer calves im-
planted with anabolic growth promotants. Forty
eight previously nonimplanted crossbred beef
heifers averaging 396 lb were assigned to one of
three treatments: 1) nonimplanted controls
(NC), 2) Revalor®-G (REV-G), and 3) Syn-
ovex®-H (SYN-H). Accumulative gain re-
sponse from day 84 through the end of the trial
was significantly faster for both implant treat-
ments than controls. Implant response was not
consistent across time; heifers in both implant
treatments gained faster than controls (P<.05)
during the early  (days 22-42) and later (days
64-84 and 85-105) weigh periods.  By day 2,
serum estradiol concentrations were increased
in REV-G (P<.05) and SYN-H (P<.01) heifers
relative to NC.  Only REV-G contains tren-
bolone acetate, and none was detected in NC
and SYN-H heifers, but serum levels in REV-G
heifers were increased on days 2 (P<.001), 4
(P<.05),  and 63 (P<.001).  Only SYN-H
contained testosterone; its level peaked by day
63 in SYN-H heifers. Throughout the study,
progesterone was higher in NC heifers than in
SYN-H or REV-G heifers, which suggests that
the exogenous steroids reduced pituitary gonad-
otropin secretion and, thus, ovarian progester-
one secretion.  Our results suggest that the
release of trenbolone and estradiol from REV-G
implants is complete by 84 days after implant-
ing.
(Key Words: Growth Promotants, Serum
Hormones, Heifers.) 
Introduction
Profit-minded cattle producers recognize
that  growth-promoting implants are indispens-
able tools for improving efficiency. Previous
KSU field studies on stocker heifers showed
that the gain response to implants depends on
both implant type and the number of implants
administered during the grazing period (Cattle-
men’s Day reports 1997 and 1998).  Those
studies also suggested that serum hormone
concentrations vary between implant types over
time. Hence, our objective was to characterize
serum hormone profiles and performance of
growing heifers implanted with Revalor®-G (40
mg trenbolone acetate and 8 mg estradiol) or
Synovex®-H (20 mg estradiol benzoate and
200 mg testosterone propionate) compared to
nonimplanted controls.
Experimental Procedures
This 147-day study was conducted from
May through October, 1997, at the KSU Beef
Cattle Research Center.  A total of 48 British
crossbred heifers averaging 396 lbs was as-
signed randomly to one of three treatments:  1)
nonimplanted control (NC), 2) Revalor-G
(REV-G) and 3) Synovex-H (SYN-H). All
heifers were checked for previous implants,
stratified by weight, and allotted randomly to
treatment using the average of  individual un-
shrunk weights on 2 previ-
81
ous weigh days (days !2 and !1).  All heifers
were fed in one pen, once per day.   The ration
was 65% sorghum silage, 20% wheat middlings,
10% rolled corn, and 5% supplement (as-fed
basis).  Table 1 shows the same ration con-
verted to a dry basis.  The targeted gain of  2
lb/day was intended to be comparable to the
gain in grazing studies conducted previously on
smooth bromegrass and winter rye.
Table 1.  Dry Matter Composition of
Growing Dieta
Ingredient % of DM
Sorghum silage 40.3
Wheat middlings 34.7
Dry-rolled corn 17.6
Supplement 7.4
aFormulated to provide 14.6% crude protein,
.43 Mcal/lb Neg, 1.04% calcium, 0.53%
phosphorus, and 25 g/ton Rumensin®.
On day 0, implants were administered
according to manufacturers’ recommendations.
Unshrunk weights and blood samples for serum
hormone analysis were collected on days 0, 2,
7, 14, 21, 42, 63, 84, 105, 126 and 147.
Samples were analyzed for  trenbolone acetate
(TBA), testosterone (T2), estrogen (E2), and
progesterone (P4). 
Live weight gain data were analyzed as a
completely randomized design with  treatment
as the sole source of variation. All hormone data
were analyzed as a split-plot analysis for re-
peated measures. The model included the effect
of treatment in the main plot (tested by the
animal within treatment variance) and time and
the treatment × time interaction in the subplot.
Treatment × time means were compared only
when a significant effect of the interaction term
was found.
Results and Discussion
Table 2 presents heifer performance by
treatment during successive weigh periods.
Daily gains of REV-G and SYN-H heifers were
similar (P>.05) to those of the NC heifers
during the first 21 days. However, heifers in
both implant treatments  gained 10 to 27%
faster than controls during the next five 20-day
weigh periods. During the final two weigh peri-
ods, SYN-H heifers gained numerically faster
than either REV-G or NC heifers.
Table 2.   Effect of Implant Type on Heifer
Daily Gains during Successive 20-Day
Weigh Periods
Treatmenta
Period of Study
(Days) NC REV-G SYN-H
         0-21 2.10 2.26 2.01
       22-42 2.49b 2.92c 2.91c
       43-63 2.12 2.44 2.40
       64-84 2.65b 3.11c 2.91bc
       85-105 1.97b 2.34bc 2.50c
     106-126 1.92 1.99 2.07
     127-147 1.79 1.50 1.96
aNC = Nonimplanted control; REV-G =
Revalor® -G; SYN-H = Synovex®-H.  All
implants were administered on day 0.
b,cValues in rows not sharing a common super-
script are different (P<.05).
Figure 1 shows the accumulative growth
responses of REV-G and SYN-H heifers
relative to controls over the 147-day study. In
contrast to earlier KSU studies where heifers
responded rapidly to SYN-H and REV-G
implantation, the implanted heifers in our study
gained similarly (P>.05) to controls during the
first 21 days. By day 42, the cumulative daily
gains of both implanted groups were numerically
greater than those of controls.  From day 84
through the end of the study, cumulative daily
gains of both implant groups were greater
(P<.05) than those of controls.  The lack of a
significant gain response to the implants early in
the study  may have been related to intensive
handling and blood sampling. Although the
amplitude of the growth response was higher for
REV-G heifers, the gain response to SYN-H
seemed to be sustained longer. These observations
are consistent with previous KSU field
trials.
Figure 2 shows the serum hormone concentrations
of the heifers throughout the 147-day
study. As expected, estradiol concentrations
were similar among all treatments on day 0. But
by day 2, estradiol levels were increased in both
REV-G (P<.05) and SYN-H (P<.01) heifers.
Serum estradiol declined rapidly in REV-G
calves, and remained similar to the level in
controls throughout the remainder of the study.
Serum estradiol was higher in SYN-H heifers
than in both control and REV-G heifers on days
7, 14, 42, and 105. The lack of a clear increase
in serum estradiol in REV-G heifers
likely reflects the lower estradiol concentration
in that implant.
As expected, only the REV-G heifers
contained measurable serum levels of
trenbolone. All samples from NC and SYN-H
heifers were below the detection limit of the
assay (10.0 pg/mL). Trenbolone was elevated
in REV-G heifers on days 2 (P<.001),
4 (P<.05), and 63 (P<.001). Thereafter,
serum trenbolone levels were similar
across the three treatments.
Averaged across the 147-day study, serum
testosterone level was higher in SYN-H heifers
(61.5+1.8 pg/mL) than in NC (41.2+6.9
pg/mL; P<.01) or REV-G (42.0+6.9 pg/mL;
P<.01) calves. That was expected because
only the SYN-H implant contained testosterone.
Progesterone concentrations trended upward
in all treatments as the study progressed,
and this is reflected (P<.001) in a day of sampling
effect. The most reasonable explanation is
that, with increasing age, more heifers were
becoming pubertal, and therefore exhibited
luteal function and increased progesterone
secretion. Averaged over all sampling days,
progesterone was higher (P<.05) in NC heifers
(1.3+.2 ng/mL) than in REV-G (.7+.2 ng/mL)
or SYN-H (.7+.2 ng/mL) calves. That is diffi-cult
to reconcile. However, the exogenous steroids
may have decreased pituitary gonadotropin
secretion, which, in turn, delayed puberty
or at least resulted in reduced progesterone
secretion.
a REV-G = Revalor-G; SYN-H = Synovex-H.
b Daily gain of implanted heifers significantly different from nonimplanted controls (P<.05).
Figure 1. Cumulative Growth Responses of Heifers to Growth Implants Relative to
Nonimplanted Controls a .
82
     -0.10
21 42 63 84 105 126 147
     0.40
     0.35
     0.30 REV-G
     0.25 SYN-H
     0.20
     0.15
     0.10
     0.05
     0.00
     -0.05
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
C
um
ul
at
iv
e
D
ai
ly
 G
ai
n 
(lb
) A
bo
ve
 C
on
tr
o
l
     Cumulative Day of Study

